Large Abdominal Hernia Repair With SurgiMend 3.0 (LAHRS 3.0)

The rate of hernia recurrence at one year following repair of a large abdominal hernia with a biologic mesh is high, ranging from 30% to 100%, with a reported historic average rate of 40%. The purpose of this study is to evaluate the rate of hernia recurrence at one year following repair with SurgiMend 3.0, an FDA-cleared novel biologic mesh, the hypothesis being that such rate will be less than 20% at one year, representing a 50% reduction over the historic rate of 40%.

Patients with surgical conditions such as i) open abdomen after a damage control operation for a traumatic or non-traumatic surgical emergency, ii) removal of infected prosthetic materials from a previous abdominal hernia repair, iii) iatrogenic injury of the bowel during adhisiolysis for repair of a large abdominal hernia, iv) contaminated operative field due to presence of an ostomy or the need for additional surgical procedures.

Inclusion Criteria:

All three of the following criteria must be present for enrollment into the study:

• Large abdominal hernia
• Inability to close the fascia primarily
• Contra-indication for the use of synthetic mesh
• Age > 18 years

Exclusion Criteria:

• Use of SurgiMend 3.0 to simply reinforce a complete closure of the fascia performed either primarily or sequentially or by component separation technique
• Inability to close the skin over the SurgiMend 3.0

• Massachusetts General Hospital
• Boston Medical Center
• Cook County Hospital
• University of Southern California
• Yale University
• Oregon Health and Science University
• State University of New York - Upstate Medical University